FDA
-
-
-
-
-
-
-
AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer
-
-
-
-
-
-
-
AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect
-
-
-
-
-
-
-
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
-
-
-
-
-
-
-
AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth
-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
-
-
-
-
-
-
-
Oppenheimer Upgrades AngioDynamics (ANGO) to Outperform
-
335,228 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


